FAP and breast carcinoma: FAP is known to be overexpressed in CAS from human breast cancer as well [27,28], and has the capacity to degrade gelatin and type 1 collagen and therefore influences the remodelling of the ECM, supporting the formation of a tumour-permissive milieu [28,51].